# Eventide: portfolio, investments and team

> Eventide is a vc firm based in United States. 4 investments on record, latest Mar 2019. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/eventide (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Eventide

Filed with the SEC to raise a fund in Nov 2023, closing $65M. Last cheque observed Mar 2019.

Quiet New fund $65M, Nov 2023 VC firm

Seed Series A Series B Healthcare

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 4 on record

Since the last cheque **2779** days **00** hrs **00** min **00** sec

Median round **$64M** Rounds led **0 of 4**

Pitch Eventide

## Eventide highlights

- 01 4 rounds on record
- 02 Mostly Series B and Series C: 67% of its rounds

## What they do

> We launched our first values-based mutual fund in 2008 and now offer eight different funds across an array of investment strategies. From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Healthcare
- **Based in:** Boston, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **4 appearances**

- **2019** 1 round
- **Mar** **[Karuna Therapeutics](https://millionrounds.com/company/karuna-therapeutics)** Series B · US · FinSMEs **$68M** With 8 others
- **2018** 3 rounds
- **Jun** **[Sutro](https://millionrounds.com/company/sutro)** Series E · US · FinSMEs **$85M** With 17 others
- **Apr** **[Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics)** Series C · US · FinSMEs **$52M** With 4 others
- **Feb** **[Avrobio](https://millionrounds.com/company/avrobio)** US · FinSMEs **$60M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **6 named**

DB **Dolores Bamford** Co-CIO of the Manager i Filing they signed

FK **Finny Kuruvilla** Co-CIO of the Manager, Managing Director i Filing they signed

JR **Jennifer Reiche** Chief Compliance Officer of the Manager i Filing they signed

KR **Kyle Rasbach** Managing Director of the Manager i Filing they signed

RJ **Robin John** Chief Executive Officer of the Manager i Filing they signed

SM **Sean Mathew** Chief Financial Officer of the Manager i Filing they signed

We also hold **5** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

New fund on file

**$65M**

raised in Nov 2023

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$64M** the round, not its cheque

Led 0 of 4 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Mar 2019

Rounds by stage said on their site

- Series B said *1*
- Series C *1*
- Series E *1*
- Seed said *-*
- Series A said *-*
- Growth said *-*

Cheques by year Led Joined

2018 2019

Often in the room with

- [Pivotal bioVenture Partners](https://millionrounds.com/fund/pivotal-life-sciences) 2

**Pitching Eventide?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Eventide. A count of rooms they were both in, not a relationship either has claimed.

[**Pivotal bioVenture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/pivotal-life-sciences)

## Recently backed

The latest companies Eventide put money into.

[**Magenta Therapeutics** $52M · Apr 2018](https://millionrounds.com/company/magenta-therapeutics)[**Avrobio** $60M · Feb 2018](https://millionrounds.com/company/avrobio)

## Quick answers about Eventide

### What does Eventide invest in?

Eventide invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Healthcare.

### How active is Eventide?

4 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2019.

### What has Eventide invested in recently?

Its most recent investments on record: Karuna Therapeutics (Series B, Mar 2019), Sutro (Series E, Jun 2018) and Magenta Therapeutics (Series C, Apr 2018).

### How big are Eventide's cheques?

The median round it joins is $64M.

### Is Eventide investing now?

No investments in the last 12 months; the latest was in Mar 2019.

### Who does Eventide invest alongside?

Most often Pivotal bioVenture Partners (2 rounds together).

### What kind of investor is Eventide?

Eventide is a VC firm based in Boston, United States.

### Has Eventide raised a new fund?

Its latest fund filing with the SEC was in Nov 2023, reporting $65M raised.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=eventide) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=eventide)
